| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, CD | 101 | 2024 | 4026 | 3.570 |
Why?
|
| CD8-Positive T-Lymphocytes | 97 | 2023 | 4479 | 3.390 |
Why?
|
| Lymphocyte Activation | 124 | 2021 | 5524 | 3.060 |
Why?
|
| Membrane Glycoproteins | 76 | 2020 | 3768 | 2.720 |
Why?
|
| T-Lymphocytes | 113 | 2024 | 10180 | 2.640 |
Why?
|
| Apoptosis Regulatory Proteins | 48 | 2013 | 1157 | 2.560 |
Why?
|
| Tumor Escape | 13 | 2023 | 349 | 2.400 |
Why?
|
| Immunotherapy | 47 | 2024 | 4445 | 2.330 |
Why?
|
| Antibodies, Monoclonal | 61 | 2023 | 9274 | 1.940 |
Why?
|
| Antigens, Surface | 36 | 2011 | 1663 | 1.820 |
Why?
|
| CD4-Positive T-Lymphocytes | 52 | 2022 | 4386 | 1.650 |
Why?
|
| Tumor Microenvironment | 33 | 2023 | 3586 | 1.610 |
Why?
|
| Lymphocytic choriomeningitis virus | 19 | 2019 | 168 | 1.510 |
Why?
|
| Immunoglobulins | 8 | 2024 | 881 | 1.370 |
Why?
|
| Peptides | 33 | 2011 | 4409 | 1.300 |
Why?
|
| Receptors, Virus | 16 | 2016 | 648 | 1.250 |
Why?
|
| Antigens, Differentiation | 33 | 2012 | 927 | 1.230 |
Why?
|
| Lymphocytic Choriomeningitis | 14 | 2022 | 132 | 1.230 |
Why?
|
| Receptors, Immunologic | 18 | 2022 | 1423 | 1.130 |
Why?
|
| Carcinoma, Renal Cell | 15 | 2024 | 3143 | 1.130 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 23 | 2009 | 906 | 1.090 |
Why?
|
| Mice | 203 | 2024 | 81183 | 1.070 |
Why?
|
| Animals | 261 | 2024 | 168757 | 1.010 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 24 | 2021 | 1038 | 0.990 |
Why?
|
| Phosphatidylserines | 7 | 2013 | 193 | 0.970 |
Why?
|
| Immune Tolerance | 27 | 2021 | 2258 | 0.960 |
Why?
|
| B-Lymphocytes | 36 | 2018 | 4665 | 0.960 |
Why?
|
| Neoplasms | 22 | 2023 | 21683 | 0.940 |
Why?
|
| Kidney Neoplasms | 14 | 2024 | 4262 | 0.940 |
Why?
|
| Membrane Proteins | 34 | 2020 | 7880 | 0.900 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 97 | 0.840 |
Why?
|
| Blood Proteins | 11 | 2004 | 1124 | 0.830 |
Why?
|
| T-Lymphocyte Subsets | 27 | 2021 | 1838 | 0.830 |
Why?
|
| Immunity | 6 | 2022 | 1012 | 0.810 |
Why?
|
| Immunoconjugates | 21 | 2014 | 901 | 0.810 |
Why?
|
| Graves Disease | 1 | 2023 | 242 | 0.800 |
Why?
|
| Arenaviridae Infections | 6 | 2013 | 51 | 0.760 |
Why?
|
| Receptors, KIR | 1 | 2020 | 113 | 0.750 |
Why?
|
| T-Lymphocytes, Regulatory | 20 | 2024 | 2988 | 0.730 |
Why?
|
| Dendritic Cells | 19 | 2021 | 2725 | 0.720 |
Why?
|
| Glioblastoma | 10 | 2023 | 3481 | 0.700 |
Why?
|
| Mice, Inbred BALB C | 50 | 2020 | 6386 | 0.690 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 9 | 2022 | 570 | 0.680 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 14 | 2 | 2009 | 12 | 0.670 |
Why?
|
| Receptors, Cell Surface | 9 | 2021 | 2866 | 0.670 |
Why?
|
| Signal Transduction | 62 | 2023 | 23403 | 0.650 |
Why?
|
| Cell Line, Tumor | 36 | 2023 | 16689 | 0.650 |
Why?
|
| Gene Expression | 25 | 2022 | 7799 | 0.620 |
Why?
|
| Ligands | 30 | 2015 | 3282 | 0.620 |
Why?
|
| Cell Hypoxia | 2 | 2020 | 675 | 0.620 |
Why?
|
| Interferon-gamma | 33 | 2023 | 3206 | 0.620 |
Why?
|
| Cytokines | 42 | 2023 | 7322 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 78 | 2021 | 21827 | 0.600 |
Why?
|
| Th1 Cells | 12 | 2016 | 1057 | 0.590 |
Why?
|
| Immunologic Memory | 12 | 2022 | 1348 | 0.590 |
Why?
|
| Lymphoma, B-Cell | 8 | 2016 | 931 | 0.580 |
Why?
|
| Antigen Presentation | 11 | 2023 | 1284 | 0.580 |
Why?
|
| Interleukin-2 | 29 | 2022 | 1904 | 0.580 |
Why?
|
| Simian immunodeficiency virus | 9 | 2022 | 846 | 0.570 |
Why?
|
| Listeria monocytogenes | 2 | 2018 | 250 | 0.560 |
Why?
|
| Histiocytes | 2 | 2021 | 103 | 0.550 |
Why?
|
| Endogenous Retroviruses | 3 | 2023 | 112 | 0.540 |
Why?
|
| Models, Immunological | 7 | 2018 | 527 | 0.540 |
Why?
|
| Immunomodulation | 2 | 2019 | 541 | 0.530 |
Why?
|
| Autoimmune Diseases | 12 | 2024 | 2133 | 0.530 |
Why?
|
| Germinal Center | 7 | 2018 | 377 | 0.520 |
Why?
|
| Apoptosis | 25 | 2016 | 9727 | 0.520 |
Why?
|
| Killer Cells, Natural | 12 | 2021 | 2133 | 0.510 |
Why?
|
| Adaptive Immunity | 4 | 2016 | 713 | 0.510 |
Why?
|
| Microsatellite Instability | 5 | 2016 | 684 | 0.490 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 9 | 2018 | 986 | 0.490 |
Why?
|
| Protein Multimerization | 2 | 2020 | 970 | 0.490 |
Why?
|
| Listeriosis | 2 | 2018 | 149 | 0.490 |
Why?
|
| Antigen-Presenting Cells | 20 | 2013 | 973 | 0.490 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2010 | 1676 | 0.480 |
Why?
|
| Lymphoma, T-Cell | 3 | 2016 | 299 | 0.480 |
Why?
|
| Fusobacterium nucleatum | 5 | 2021 | 162 | 0.480 |
Why?
|
| Humans | 270 | 2024 | 744343 | 0.480 |
Why?
|
| RNA Splicing | 1 | 2018 | 907 | 0.470 |
Why?
|
| Cell Membrane | 7 | 2016 | 3748 | 0.470 |
Why?
|
| Bronchial Hyperreactivity | 7 | 2019 | 319 | 0.460 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 3 | 2021 | 82 | 0.450 |
Why?
|
| CD40 Ligand | 5 | 2014 | 526 | 0.430 |
Why?
|
| T-Lymphocytes, Cytotoxic | 9 | 2018 | 1821 | 0.430 |
Why?
|
| Flow Cytometry | 34 | 2018 | 5974 | 0.420 |
Why?
|
| Colonic Neoplasms | 4 | 2019 | 2541 | 0.420 |
Why?
|
| Autoimmunity | 7 | 2018 | 1349 | 0.420 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 713 | 0.420 |
Why?
|
| Mice, Knockout | 43 | 2021 | 14557 | 0.410 |
Why?
|
| Graft vs Host Disease | 8 | 2022 | 2957 | 0.410 |
Why?
|
| Melanoma | 10 | 2023 | 5510 | 0.410 |
Why?
|
| Clonal Anergy | 13 | 2001 | 169 | 0.410 |
Why?
|
| Lymphocyte Subsets | 4 | 2016 | 315 | 0.400 |
Why?
|
| Cancer Vaccines | 5 | 2021 | 1023 | 0.400 |
Why?
|
| GPI-Linked Proteins | 8 | 2018 | 434 | 0.400 |
Why?
|
| Immune Evasion | 3 | 2023 | 360 | 0.400 |
Why?
|
| Receptors, Antigen, T-Cell | 21 | 2022 | 2540 | 0.390 |
Why?
|
| Antineoplastic Agents | 13 | 2021 | 13695 | 0.390 |
Why?
|
| Mice, Transgenic | 32 | 2019 | 9734 | 0.390 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 5 | 2023 | 265 | 0.380 |
Why?
|
| Histiocytic Disorders, Malignant | 1 | 2010 | 16 | 0.380 |
Why?
|
| Neoplasms, Experimental | 4 | 2019 | 1276 | 0.380 |
Why?
|
| Immunity, Innate | 9 | 2023 | 2958 | 0.380 |
Why?
|
| Phagocytosis | 6 | 2016 | 1539 | 0.370 |
Why?
|
| Antigens, Neoplasm | 12 | 2024 | 1988 | 0.370 |
Why?
|
| Recombinant Fusion Proteins | 12 | 2013 | 3772 | 0.370 |
Why?
|
| Immune System | 4 | 2019 | 805 | 0.370 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 9 | 2000 | 318 | 0.370 |
Why?
|
| Immunosuppressive Agents | 9 | 2022 | 4149 | 0.360 |
Why?
|
| Cloning, Molecular | 22 | 2008 | 4320 | 0.360 |
Why?
|
| Antibodies, Blocking | 10 | 2019 | 253 | 0.350 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2023 | 1142 | 0.350 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2009 | 9 | 0.350 |
Why?
|
| Th2 Cells | 7 | 2016 | 1061 | 0.350 |
Why?
|
| Disease Models, Animal | 28 | 2023 | 18029 | 0.350 |
Why?
|
| Langerhans Cells | 1 | 2010 | 173 | 0.350 |
Why?
|
| Interleukin-10 | 10 | 2018 | 1200 | 0.340 |
Why?
|
| Hepatitis A virus | 4 | 2012 | 15 | 0.340 |
Why?
|
| Bone Marrow Transplantation | 10 | 2016 | 2765 | 0.340 |
Why?
|
| Immunophenotyping | 12 | 2019 | 1880 | 0.330 |
Why?
|
| Hepacivirus | 8 | 2013 | 1379 | 0.330 |
Why?
|
| Colorectal Neoplasms | 9 | 2021 | 6773 | 0.320 |
Why?
|
| Lymphocytes | 5 | 2017 | 2617 | 0.320 |
Why?
|
| Lung Neoplasms | 12 | 2021 | 13102 | 0.320 |
Why?
|
| Cell Differentiation | 21 | 2023 | 11483 | 0.320 |
Why?
|
| Molecular Sequence Data | 46 | 2015 | 18111 | 0.310 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 5 | 2021 | 1378 | 0.310 |
Why?
|
| Immunohistochemistry | 22 | 2021 | 11366 | 0.310 |
Why?
|
| Virus Diseases | 4 | 2023 | 711 | 0.310 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 7 | 2021 | 835 | 0.310 |
Why?
|
| Recombinant Proteins | 14 | 2012 | 6622 | 0.310 |
Why?
|
| Cells, Cultured | 40 | 2017 | 19229 | 0.310 |
Why?
|
| Semaphorins | 2 | 1998 | 101 | 0.290 |
Why?
|
| Lectins, C-Type | 5 | 2021 | 588 | 0.290 |
Why?
|
| Cytotoxicity, Immunologic | 8 | 2019 | 1369 | 0.290 |
Why?
|
| Interleukin-4 | 16 | 2015 | 1147 | 0.280 |
Why?
|
| Immunoblastic Lymphadenopathy | 1 | 2006 | 35 | 0.280 |
Why?
|
| Viral Vaccines | 4 | 2021 | 636 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 9 | 3 | 2020 | 535 | 0.280 |
Why?
|
| HIV Infections | 15 | 2022 | 16718 | 0.280 |
Why?
|
| Lymphoid Tissue | 4 | 2021 | 455 | 0.280 |
Why?
|
| Adoptive Transfer | 14 | 2018 | 844 | 0.280 |
Why?
|
| Amino Acid Sequence | 37 | 2015 | 13815 | 0.270 |
Why?
|
| Anti-Retroviral Agents | 3 | 2022 | 1715 | 0.270 |
Why?
|
| Hepatitis C, Chronic | 6 | 2013 | 1031 | 0.270 |
Why?
|
| Carbonic Anhydrases | 2 | 2024 | 115 | 0.260 |
Why?
|
| Gene Expression Profiling | 13 | 2021 | 9438 | 0.250 |
Why?
|
| Hodgkin Disease | 4 | 2017 | 1415 | 0.250 |
Why?
|
| Epitopes, T-Lymphocyte | 8 | 2013 | 880 | 0.250 |
Why?
|
| Female | 100 | 2023 | 380194 | 0.250 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2017 | 538 | 0.250 |
Why?
|
| Cricetinae | 18 | 2007 | 2472 | 0.250 |
Why?
|
| Down-Regulation | 12 | 2023 | 3002 | 0.250 |
Why?
|
| Immunologic Surveillance | 2 | 2017 | 93 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 4462 | 0.250 |
Why?
|
| Antigens | 7 | 2015 | 1466 | 0.240 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2021 | 5221 | 0.240 |
Why?
|
| Proto-Oncogene Proteins B-raf | 5 | 2018 | 2043 | 0.240 |
Why?
|
| Jurkat Cells | 9 | 2020 | 743 | 0.240 |
Why?
|
| RNA, Messenger | 31 | 2016 | 13033 | 0.240 |
Why?
|
| Binding, Competitive | 3 | 2018 | 1157 | 0.240 |
Why?
|
| Antibodies | 11 | 2024 | 2460 | 0.240 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2020 | 1475 | 0.230 |
Why?
|
| Macaca mulatta | 10 | 2022 | 2375 | 0.230 |
Why?
|
| Cell Line | 33 | 2020 | 15997 | 0.230 |
Why?
|
| Gene Expression Regulation | 21 | 2018 | 12072 | 0.230 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2015 | 153 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 20 | 2017 | 6314 | 0.230 |
Why?
|
| Asthma | 10 | 2019 | 6011 | 0.230 |
Why?
|
| Chemokine CX3CL1 | 1 | 2023 | 58 | 0.230 |
Why?
|
| Isoantigens | 8 | 2007 | 567 | 0.230 |
Why?
|
| Transfection | 28 | 2013 | 5892 | 0.230 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2021 | 611 | 0.230 |
Why?
|
| Receptors, Thyrotropin | 1 | 2023 | 45 | 0.230 |
Why?
|
| Up-Regulation | 15 | 2018 | 4217 | 0.230 |
Why?
|
| Proteins | 13 | 2008 | 6103 | 0.230 |
Why?
|
| HIV-1 | 11 | 2018 | 6939 | 0.230 |
Why?
|
| Malaria, Falciparum | 1 | 2012 | 1077 | 0.220 |
Why?
|
| Antibody Formation | 7 | 2015 | 1402 | 0.220 |
Why?
|
| COS Cells | 9 | 2020 | 1161 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2023 | 5172 | 0.220 |
Why?
|
| Receptors, Interleukin-2 | 8 | 2004 | 573 | 0.220 |
Why?
|
| Lymphocyte Count | 9 | 2019 | 793 | 0.220 |
Why?
|
| Staining and Labeling | 4 | 2017 | 1100 | 0.220 |
Why?
|
| Genetic Engineering | 2 | 2014 | 951 | 0.220 |
Why?
|
| Macrophages | 11 | 2019 | 5655 | 0.220 |
Why?
|
| CHO Cells | 14 | 2003 | 1406 | 0.220 |
Why?
|
| Adjuvants, Immunologic | 3 | 2014 | 1000 | 0.220 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2023 | 130 | 0.210 |
Why?
|
| Plasmodium falciparum | 1 | 2012 | 1732 | 0.210 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 137 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 9 | 2020 | 11524 | 0.200 |
Why?
|
| Interleukin-12 | 5 | 2018 | 579 | 0.200 |
Why?
|
| Protein Binding | 11 | 2023 | 9386 | 0.200 |
Why?
|
| Melanoma, Experimental | 4 | 2019 | 561 | 0.200 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 200 | 0.200 |
Why?
|
| Viral Matrix Proteins | 2 | 2012 | 186 | 0.200 |
Why?
|
| Multigene Family | 7 | 2010 | 1102 | 0.200 |
Why?
|
| Viral Load | 10 | 2022 | 3299 | 0.200 |
Why?
|
| Mice, Inbred NOD | 11 | 2021 | 1878 | 0.190 |
Why?
|
| Binding Sites | 5 | 2018 | 6114 | 0.190 |
Why?
|
| Carcinoma | 4 | 2016 | 2375 | 0.190 |
Why?
|
| Transplantation Tolerance | 3 | 2013 | 617 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 3846 | 0.190 |
Why?
|
| Fusobacterium Infections | 1 | 2021 | 53 | 0.190 |
Why?
|
| Cell Proliferation | 17 | 2020 | 10481 | 0.190 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 6364 | 0.190 |
Why?
|
| Self Tolerance | 3 | 2011 | 125 | 0.190 |
Why?
|
| Clone Cells | 17 | 2020 | 1692 | 0.180 |
Why?
|
| Thyroid Neoplasms | 3 | 2019 | 2282 | 0.180 |
Why?
|
| Transcription, Genetic | 11 | 2014 | 7722 | 0.180 |
Why?
|
| Reed-Sternberg Cells | 2 | 2017 | 73 | 0.180 |
Why?
|
| Indoles | 3 | 2018 | 1839 | 0.180 |
Why?
|
| Interleukins | 10 | 2015 | 791 | 0.180 |
Why?
|
| Virus Replication | 6 | 2018 | 2534 | 0.180 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2020 | 90 | 0.180 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2019 | 20 | 0.180 |
Why?
|
| Cell Movement | 4 | 2010 | 5217 | 0.180 |
Why?
|
| Rats | 7 | 2023 | 24260 | 0.180 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1998 | 222 | 0.170 |
Why?
|
| Thyrotropin | 1 | 2023 | 849 | 0.170 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 1813 | 0.170 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2019 | 51 | 0.170 |
Why?
|
| Herpesvirus 1, Human | 3 | 2018 | 743 | 0.170 |
Why?
|
| Histone Demethylases | 2 | 2020 | 321 | 0.170 |
Why?
|
| Myelin Proteolipid Protein | 1 | 1999 | 107 | 0.170 |
Why?
|
| Herpes Simplex | 2 | 2014 | 470 | 0.170 |
Why?
|
| Sulfonamides | 3 | 2018 | 1938 | 0.170 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 234 | 0.170 |
Why?
|
| Neoplasm Proteins | 6 | 2019 | 3703 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2021 | 8428 | 0.170 |
Why?
|
| Viral Envelope Proteins | 2 | 2020 | 635 | 0.170 |
Why?
|
| Ovalbumin | 8 | 2019 | 719 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2018 | 1692 | 0.160 |
Why?
|
| Prognosis | 14 | 2022 | 29063 | 0.160 |
Why?
|
| Male | 63 | 2022 | 350118 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2017 | 322 | 0.160 |
Why?
|
| Communicable Diseases | 1 | 2007 | 880 | 0.160 |
Why?
|
| Host-Pathogen Interactions | 4 | 2015 | 1477 | 0.160 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2018 | 55 | 0.160 |
Why?
|
| Fatty Acids | 2 | 2017 | 1809 | 0.160 |
Why?
|
| HIV | 4 | 2010 | 1604 | 0.160 |
Why?
|
| Receptors, CXCR3 | 1 | 2019 | 237 | 0.160 |
Why?
|
| Organ Specificity | 5 | 2010 | 2008 | 0.160 |
Why?
|
| Osteoclasts | 1 | 2022 | 729 | 0.160 |
Why?
|
| Cyclin D | 1 | 2017 | 71 | 0.150 |
Why?
|
| Myeloid Cells | 2 | 2023 | 810 | 0.150 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2020 | 248 | 0.150 |
Why?
|
| Viremia | 6 | 2022 | 736 | 0.150 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 4838 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2007 | 3420 | 0.150 |
Why?
|
| Hepatitis C | 4 | 2008 | 1591 | 0.150 |
Why?
|
| Phosphorylation | 6 | 2021 | 8436 | 0.150 |
Why?
|
| Interleukin-17 | 2 | 2017 | 899 | 0.150 |
Why?
|
| Base Sequence | 25 | 2007 | 12797 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 3 | 2009 | 4803 | 0.150 |
Why?
|
| Brain Neoplasms | 4 | 2020 | 8863 | 0.150 |
Why?
|
| T-Box Domain Proteins | 4 | 2014 | 471 | 0.150 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2019 | 671 | 0.150 |
Why?
|
| Transplantation, Homologous | 8 | 2019 | 4776 | 0.150 |
Why?
|
| DNA | 7 | 2007 | 7301 | 0.150 |
Why?
|
| DNA, Bacterial | 3 | 2017 | 1465 | 0.150 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2016 | 570 | 0.150 |
Why?
|
| Liver | 8 | 2013 | 7474 | 0.140 |
Why?
|
| Lung | 3 | 2014 | 9856 | 0.140 |
Why?
|
| Interferon Type I | 3 | 2019 | 542 | 0.140 |
Why?
|
| Cullin Proteins | 1 | 2017 | 180 | 0.140 |
Why?
|
| Glycolysis | 3 | 2016 | 827 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2020 | 6538 | 0.140 |
Why?
|
| Disease Progression | 9 | 2022 | 13284 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 13 | 2015 | 6171 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2004 | 2839 | 0.140 |
Why?
|
| Cytosine Deaminase | 1 | 2016 | 68 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 4 | 2017 | 2007 | 0.140 |
Why?
|
| Azepines | 1 | 2018 | 336 | 0.140 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2016 | 23 | 0.140 |
Why?
|
| Histiocytosis, Sinus | 1 | 2016 | 47 | 0.140 |
Why?
|
| Brain Edema | 1 | 2020 | 617 | 0.140 |
Why?
|
| Tissue Embedding | 1 | 2015 | 43 | 0.140 |
Why?
|
| Tumor Necrosis Factors | 2 | 2014 | 109 | 0.140 |
Why?
|
| Epitopes | 6 | 2021 | 2571 | 0.140 |
Why?
|
| Spleen | 15 | 2018 | 2362 | 0.130 |
Why?
|
| Sarcoma | 2 | 2019 | 1897 | 0.130 |
Why?
|
| Receptors, LDL | 2 | 2016 | 475 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2021 | 2505 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2015 | 4751 | 0.130 |
Why?
|
| Blotting, Northern | 9 | 2001 | 1581 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2018 | 2245 | 0.130 |
Why?
|
| Graft Survival | 7 | 2013 | 3737 | 0.130 |
Why?
|
| 3T3 Cells | 9 | 2010 | 1101 | 0.130 |
Why?
|
| Phenylurea Compounds | 1 | 2019 | 528 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2019 | 5535 | 0.130 |
Why?
|
| Genomic Instability | 1 | 2019 | 695 | 0.130 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2015 | 41 | 0.130 |
Why?
|
| rap1 GTP-Binding Proteins | 2 | 2005 | 60 | 0.130 |
Why?
|
| Tumor Burden | 3 | 2015 | 1915 | 0.130 |
Why?
|
| Receptors, OX40 | 1 | 2014 | 43 | 0.130 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 388 | 0.130 |
Why?
|
| Chronic Disease | 16 | 2014 | 9146 | 0.130 |
Why?
|
| Granzymes | 4 | 2019 | 271 | 0.130 |
Why?
|
| Combined Modality Therapy | 5 | 2018 | 8642 | 0.130 |
Why?
|
| Mediastinal Neoplasms | 2 | 2015 | 423 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 2557 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2023 | 2035 | 0.120 |
Why?
|
| Neoplasm Staging | 7 | 2019 | 11031 | 0.120 |
Why?
|
| Translocation, Genetic | 3 | 2015 | 1420 | 0.120 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2015 | 76 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 320 | 0.120 |
Why?
|
| Barrett Esophagus | 2 | 2016 | 494 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1116 | 0.120 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 3 | 2013 | 52 | 0.120 |
Why?
|
| Colitis | 1 | 2022 | 1170 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2015 | 3870 | 0.120 |
Why?
|
| Ovarian Follicle | 1 | 2016 | 247 | 0.120 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2016 | 171 | 0.120 |
Why?
|
| Intestinal Mucosa | 4 | 2013 | 3036 | 0.120 |
Why?
|
| Epidemiology | 1 | 2017 | 287 | 0.120 |
Why?
|
| Urothelium | 1 | 2016 | 277 | 0.120 |
Why?
|
| Endothelium, Vascular | 2 | 2003 | 4456 | 0.120 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2013 | 484 | 0.120 |
Why?
|
| Lymphoma | 3 | 2013 | 1877 | 0.120 |
Why?
|
| Lipolysis | 1 | 2015 | 210 | 0.120 |
Why?
|
| Lymphotoxin-alpha | 2 | 2009 | 96 | 0.120 |
Why?
|
| Hepatitis A | 2 | 2012 | 133 | 0.120 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2016 | 252 | 0.120 |
Why?
|
| Cell Nucleus | 4 | 2020 | 2969 | 0.120 |
Why?
|
| Quinolines | 1 | 2019 | 732 | 0.120 |
Why?
|
| Pathology, Molecular | 1 | 2017 | 326 | 0.120 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 5853 | 0.110 |
Why?
|
| Vulvar Neoplasms | 1 | 2016 | 272 | 0.110 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 390 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2020 | 1951 | 0.110 |
Why?
|
| Oligopeptides | 1 | 1999 | 1189 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 6 | 2004 | 1602 | 0.110 |
Why?
|
| Heart Transplantation | 7 | 2013 | 3110 | 0.110 |
Why?
|
| Protein Conformation | 5 | 2010 | 4011 | 0.110 |
Why?
|
| Thymoma | 3 | 2000 | 186 | 0.110 |
Why?
|
| Software | 1 | 2007 | 4443 | 0.110 |
Why?
|
| Cell Communication | 5 | 2010 | 1621 | 0.110 |
Why?
|
| DNA, Complementary | 7 | 2000 | 2050 | 0.110 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2014 | 192 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2019 | 3557 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2016 | 640 | 0.110 |
Why?
|
| Triazoles | 1 | 2018 | 911 | 0.110 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 477 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 2 | 2017 | 2734 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 528 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 4 | 2021 | 1978 | 0.110 |
Why?
|
| Testis | 1 | 2016 | 803 | 0.110 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 381 | 0.110 |
Why?
|
| Antigens, Viral | 3 | 2012 | 1035 | 0.110 |
Why?
|
| Bacterial Translocation | 1 | 2012 | 73 | 0.100 |
Why?
|
| Growth Inhibitors | 2 | 2011 | 385 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 350 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 4 | 2015 | 1799 | 0.100 |
Why?
|
| Virus Attachment | 1 | 2012 | 55 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2020 | 2849 | 0.100 |
Why?
|
| Herpesvirus 4, Human | 3 | 2013 | 1041 | 0.100 |
Why?
|
| Bone Marrow Purging | 1 | 1991 | 109 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 1149 | 0.100 |
Why?
|
| Lymphocyte Culture Test, Mixed | 7 | 1997 | 517 | 0.100 |
Why?
|
| HEK293 Cells | 5 | 2020 | 4204 | 0.100 |
Why?
|
| Middle Aged | 33 | 2021 | 213383 | 0.100 |
Why?
|
| Fluorouracil | 1 | 2016 | 1619 | 0.100 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 407 | 0.100 |
Why?
|
| Mucous Membrane | 1 | 2015 | 673 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 903 | 0.100 |
Why?
|
| Genetic Linkage | 2 | 2010 | 2421 | 0.100 |
Why?
|
| Coculture Techniques | 5 | 2016 | 1341 | 0.100 |
Why?
|
| Aging | 3 | 2015 | 8664 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2013 | 4554 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2012 | 281 | 0.100 |
Why?
|
| Histocompatibility Antigens Class I | 5 | 2021 | 1366 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2015 | 459 | 0.100 |
Why?
|
| Carcinoma in Situ | 1 | 2017 | 806 | 0.100 |
Why?
|
| Immunity, Mucosal | 2 | 2018 | 490 | 0.100 |
Why?
|
| Natural Killer T-Cells | 2 | 2013 | 316 | 0.100 |
Why?
|
| Aged | 26 | 2021 | 163280 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1992 | 323 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 726 | 0.100 |
Why?
|
| Metabolomics | 1 | 2019 | 1484 | 0.100 |
Why?
|
| Breast Neoplasms | 5 | 2022 | 20822 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2012 | 274 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 578 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 4 | 2019 | 768 | 0.090 |
Why?
|
| Immunity, Cellular | 6 | 2018 | 1607 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2016 | 506 | 0.090 |
Why?
|
| Mucin-3 | 1 | 2010 | 6 | 0.090 |
Why?
|
| Dimerization | 3 | 2008 | 893 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2013 | 581 | 0.090 |
Why?
|
| Skin Neoplasms | 2 | 2020 | 5686 | 0.090 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 2187 | 0.090 |
Why?
|
| Histiocytic Sarcoma | 1 | 2010 | 44 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2011 | 3336 | 0.090 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2010 | 154 | 0.090 |
Why?
|
| Trigeminal Ganglion | 1 | 2011 | 186 | 0.090 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2017 | 808 | 0.090 |
Why?
|
| Allergy and Immunology | 1 | 2011 | 169 | 0.090 |
Why?
|
| Survival Rate | 7 | 2020 | 12788 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2021 | 2915 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1029 | 0.090 |
Why?
|
| Blotting, Southern | 4 | 2014 | 803 | 0.090 |
Why?
|
| Antigens, CD19 | 1 | 2012 | 380 | 0.090 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2009 | 38 | 0.090 |
Why?
|
| Aortic Diseases | 1 | 2016 | 742 | 0.090 |
Why?
|
| Adult | 28 | 2021 | 214055 | 0.090 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 949 | 0.090 |
Why?
|
| NIH 3T3 Cells | 2 | 2010 | 677 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2017 | 1101 | 0.090 |
Why?
|
| Mutation | 11 | 2020 | 29786 | 0.090 |
Why?
|
| Lymphokines | 1 | 1992 | 949 | 0.090 |
Why?
|
| Peptide Fragments | 4 | 2009 | 5097 | 0.090 |
Why?
|
| Mice, SCID | 5 | 2016 | 2716 | 0.090 |
Why?
|
| Placenta | 1 | 2018 | 1698 | 0.090 |
Why?
|
| Macrophage Activation | 2 | 2003 | 558 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 804 | 0.090 |
Why?
|
| STAT Transcription Factors | 2 | 2023 | 182 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2019 | 4420 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 4034 | 0.090 |
Why?
|
| Viruses | 1 | 2013 | 374 | 0.080 |
Why?
|
| Polymorphism, Genetic | 4 | 2011 | 4328 | 0.080 |
Why?
|
| Bronchi | 1 | 2013 | 840 | 0.080 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 2 | 2022 | 88 | 0.080 |
Why?
|
| MicroRNAs | 3 | 2015 | 3752 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2001 | 4740 | 0.080 |
Why?
|
| Blotting, Western | 7 | 2015 | 5179 | 0.080 |
Why?
|
| Uveitis, Posterior | 1 | 2009 | 44 | 0.080 |
Why?
|
| Janus Kinases | 2 | 2023 | 244 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2014 | 1586 | 0.080 |
Why?
|
| Neutrophils | 3 | 2017 | 3719 | 0.080 |
Why?
|
| Esophageal Neoplasms | 2 | 2016 | 1583 | 0.080 |
Why?
|
| Immunoglobulin G | 4 | 2015 | 4560 | 0.080 |
Why?
|
| Ki-67 Antigen | 3 | 2018 | 644 | 0.080 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 990 | 0.080 |
Why?
|
| Cell Compartmentation | 2 | 2008 | 402 | 0.080 |
Why?
|
| Hypersensitivity | 3 | 2008 | 1102 | 0.080 |
Why?
|
| Human T-lymphotropic virus 1 | 2 | 2000 | 140 | 0.080 |
Why?
|
| Virus Latency | 1 | 2011 | 358 | 0.080 |
Why?
|
| Histoplasma | 1 | 2008 | 41 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2022 | 2649 | 0.080 |
Why?
|
| Tuberculosis | 1 | 2021 | 1912 | 0.080 |
Why?
|
| Immunocompetence | 3 | 2018 | 137 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 354 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2016 | 1345 | 0.080 |
Why?
|
| HIV Long-Term Survivors | 1 | 2008 | 126 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2727 | 0.080 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 738 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 2425 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2019 | 147 | 0.080 |
Why?
|
| Histoplasmosis | 1 | 2008 | 66 | 0.080 |
Why?
|
| RNA, Double-Stranded | 2 | 2020 | 290 | 0.080 |
Why?
|
| Enteritis | 1 | 2009 | 165 | 0.080 |
Why?
|
| Inflammation | 6 | 2022 | 10638 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 1513 | 0.080 |
Why?
|
| Virus Internalization | 2 | 2013 | 501 | 0.080 |
Why?
|
| Tetanus Toxoid | 3 | 2004 | 193 | 0.080 |
Why?
|
| Antiviral Agents | 4 | 2013 | 2987 | 0.080 |
Why?
|
| Receptor Cross-Talk | 2 | 2016 | 119 | 0.080 |
Why?
|
| Atherosclerosis | 2 | 2016 | 3445 | 0.070 |
Why?
|
| Genes, Regulator | 3 | 2023 | 378 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 895 | 0.070 |
Why?
|
| Alternative Splicing | 3 | 1999 | 1117 | 0.070 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2001 | 291 | 0.070 |
Why?
|
| Cell Lineage | 2 | 2014 | 2504 | 0.070 |
Why?
|
| Respiratory System | 2 | 2015 | 557 | 0.070 |
Why?
|
| Leukemia, B-Cell | 2 | 1997 | 86 | 0.070 |
Why?
|
| Graft Rejection | 8 | 2012 | 4397 | 0.070 |
Why?
|
| Rectal Neoplasms | 1 | 2016 | 1206 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2009 | 675 | 0.070 |
Why?
|
| Cell Separation | 5 | 2016 | 1751 | 0.070 |
Why?
|
| Phenotype | 10 | 2019 | 16365 | 0.070 |
Why?
|
| Inflammation Mediators | 3 | 2019 | 1889 | 0.070 |
Why?
|
| Cell Division | 8 | 2003 | 4568 | 0.070 |
Why?
|
| Lymph Nodes | 5 | 2012 | 3474 | 0.070 |
Why?
|
| HLA-DR7 Antigen | 6 | 1996 | 27 | 0.070 |
Why?
|
| Stomach Neoplasms | 1 | 2016 | 1333 | 0.070 |
Why?
|
| Vincristine | 3 | 2019 | 1039 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2022 | 53288 | 0.070 |
Why?
|
| Keratitis | 1 | 2009 | 268 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2012 | 1596 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2017 | 3023 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 3712 | 0.070 |
Why?
|
| Genes, MHC Class II | 2 | 2000 | 457 | 0.070 |
Why?
|
| Thymus Neoplasms | 2 | 2000 | 268 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 4 | 2018 | 1376 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2015 | 2575 | 0.070 |
Why?
|
| Meningioma | 1 | 2015 | 1209 | 0.070 |
Why?
|
| Survival Analysis | 5 | 2021 | 10252 | 0.070 |
Why?
|
| Factor VIII | 1 | 2008 | 347 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2006 | 2455 | 0.070 |
Why?
|
| Glioma | 1 | 2021 | 3401 | 0.070 |
Why?
|
| Adenoma | 1 | 2016 | 2174 | 0.070 |
Why?
|
| Disease-Free Survival | 4 | 2017 | 6895 | 0.070 |
Why?
|
| Meningeal Neoplasms | 1 | 2015 | 1241 | 0.070 |
Why?
|
| Monocytes | 4 | 2013 | 2596 | 0.070 |
Why?
|
| Administration, Intranasal | 2 | 2020 | 446 | 0.070 |
Why?
|
| SAIDS Vaccines | 1 | 2007 | 166 | 0.070 |
Why?
|
| Interleukin-13 | 3 | 2015 | 389 | 0.070 |
Why?
|
| Mice, Nude | 4 | 2021 | 3689 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 1587 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2020 | 2751 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 1991 | 1381 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 3523 | 0.060 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 1363 | 0.060 |
Why?
|
| Integrin alpha Chains | 1 | 2005 | 97 | 0.060 |
Why?
|
| Cell Death | 2 | 2020 | 1706 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2014 | 805 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 3 | 2020 | 116 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2023 | 2109 | 0.060 |
Why?
|
| Aspirin | 1 | 2017 | 3282 | 0.060 |
Why?
|
| Hemophilia A | 1 | 2008 | 351 | 0.060 |
Why?
|
| Dry Eye Syndromes | 1 | 2009 | 386 | 0.060 |
Why?
|
| Autoantigens | 3 | 2009 | 892 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2014 | 3690 | 0.060 |
Why?
|
| Immunoglobulin Fc Fragments | 4 | 2002 | 279 | 0.060 |
Why?
|
| Transplantation Immunology | 3 | 2012 | 546 | 0.060 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2006 | 124 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 3129 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4186 | 0.060 |
Why?
|
| Formates | 1 | 2023 | 42 | 0.060 |
Why?
|
| Acute Disease | 6 | 2013 | 7149 | 0.060 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2006 | 236 | 0.060 |
Why?
|
| Prednisone | 3 | 2019 | 1574 | 0.060 |
Why?
|
| Rats, Inbred Lew | 4 | 2010 | 1162 | 0.060 |
Why?
|
| Models, Animal | 1 | 2010 | 2171 | 0.060 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2020 | 890 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 2020 | 0.060 |
Why?
|
| Cell Survival | 5 | 2015 | 5882 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2008 | 1539 | 0.060 |
Why?
|
| Contractile Proteins | 1 | 2004 | 246 | 0.060 |
Why?
|
| Cell Adhesion | 9 | 2005 | 3144 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2017 | 9239 | 0.060 |
Why?
|
| Retinal Ganglion Cells | 1 | 2009 | 770 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2009 | 818 | 0.060 |
Why?
|
| Tissue Donors | 2 | 2007 | 2240 | 0.060 |
Why?
|
| Carrier Proteins | 5 | 2009 | 5021 | 0.060 |
Why?
|
| Telomerase | 1 | 2008 | 730 | 0.060 |
Why?
|
| DNA-Binding Proteins | 7 | 2020 | 9648 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2021 | 2938 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 6234 | 0.060 |
Why?
|
| STAT6 Transcription Factor | 4 | 2004 | 199 | 0.060 |
Why?
|
| Corneal Transplantation | 1 | 2007 | 386 | 0.060 |
Why?
|
| HLA-A2 Antigen | 2 | 2000 | 213 | 0.060 |
Why?
|
| Metals | 1 | 2007 | 719 | 0.060 |
Why?
|
| Vaccination | 3 | 2021 | 3278 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2007 | 992 | 0.060 |
Why?
|
| Bone Marrow Cells | 3 | 2016 | 2513 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2006 | 675 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 4 | 2016 | 1613 | 0.060 |
Why?
|
| Drug Therapy, Combination | 3 | 2022 | 6489 | 0.060 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2022 | 24 | 0.060 |
Why?
|
| Germ-Free Life | 1 | 2023 | 188 | 0.050 |
Why?
|
| Friends | 1 | 2024 | 154 | 0.050 |
Why?
|
| Pyruvate Carboxylase | 1 | 2022 | 17 | 0.050 |
Why?
|
| Cyclophosphamide | 3 | 2019 | 2242 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2018 | 1836 | 0.050 |
Why?
|
| Respiratory Mucosa | 1 | 2006 | 427 | 0.050 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2022 | 49 | 0.050 |
Why?
|
| Lymphoma, Follicular | 2 | 1997 | 435 | 0.050 |
Why?
|
| Exons | 4 | 2001 | 2437 | 0.050 |
Why?
|
| Hepatitis B, Chronic | 1 | 2007 | 393 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2020 | 1338 | 0.050 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 57776 | 0.050 |
Why?
|
| Transcription Factors | 6 | 2023 | 12208 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2011 | 1253 | 0.050 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2007 | 745 | 0.050 |
Why?
|
| Leukemia, Myeloid | 2 | 1996 | 707 | 0.050 |
Why?
|
| Doxorubicin | 3 | 2019 | 2234 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2021 | 2503 | 0.050 |
Why?
|
| Immunologic Factors | 3 | 2022 | 1580 | 0.050 |
Why?
|
| Cell Cycle | 3 | 2017 | 2967 | 0.050 |
Why?
|
| Precipitin Tests | 2 | 2003 | 829 | 0.050 |
Why?
|
| Glutathione Transferase | 3 | 2004 | 595 | 0.050 |
Why?
|
| Succinic Acid | 1 | 2022 | 83 | 0.050 |
Why?
|
| src Homology Domains | 2 | 2020 | 364 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2001 | 1155 | 0.050 |
Why?
|
| Ligases | 1 | 2003 | 333 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5442 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2013 | 1479 | 0.050 |
Why?
|
| DNA Primers | 4 | 2014 | 2892 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 1999 | 2256 | 0.050 |
Why?
|
| Pyrones | 1 | 2021 | 36 | 0.050 |
Why?
|
| Trans-Activators | 6 | 2014 | 2924 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2004 | 595 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2023 | 220 | 0.050 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2022 | 310 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2014 | 2440 | 0.050 |
Why?
|
| Multiple Myeloma | 2 | 2016 | 5181 | 0.050 |
Why?
|
| NF-kappa B | 3 | 2018 | 2499 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2021 | 126 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2007 | 1352 | 0.050 |
Why?
|
| HLA-DR Antigens | 3 | 2001 | 645 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2003 | 482 | 0.050 |
Why?
|
| Losartan | 1 | 2023 | 299 | 0.050 |
Why?
|
| Gene Amplification | 2 | 2016 | 1063 | 0.050 |
Why?
|
| Models, Biological | 5 | 2020 | 9583 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 2916 | 0.050 |
Why?
|
| Alleles | 2 | 2010 | 6933 | 0.050 |
Why?
|
| Neoplasm Metastasis | 3 | 2016 | 4851 | 0.050 |
Why?
|
| Gene Dosage | 2 | 2016 | 1252 | 0.050 |
Why?
|
| Pan troglodytes | 2 | 2013 | 229 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 2 | 1998 | 94 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2703 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2020 | 3128 | 0.050 |
Why?
|
| Bacterial Load | 1 | 2021 | 153 | 0.050 |
Why?
|
| Lipoproteins, LDL | 2 | 2016 | 640 | 0.050 |
Why?
|
| Genes | 4 | 2001 | 1893 | 0.050 |
Why?
|
| Micronucleus Tests | 1 | 2019 | 23 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2023 | 367 | 0.050 |
Why?
|
| Lymphocyte Depletion | 2 | 2014 | 608 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 1106 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2020 | 10943 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2023 | 520 | 0.050 |
Why?
|
| Myocarditis | 1 | 2007 | 771 | 0.040 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2020 | 131 | 0.040 |
Why?
|
| Chemokine CXCL9 | 1 | 2019 | 132 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2010 | 5456 | 0.040 |
Why?
|
| Virion | 2 | 2013 | 433 | 0.040 |
Why?
|
| Treatment Outcome | 8 | 2019 | 63114 | 0.040 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1999 | 93 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2007 | 4161 | 0.040 |
Why?
|
| OX40 Ligand | 2 | 2014 | 51 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2022 | 669 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2020 | 1723 | 0.040 |
Why?
|
| Drug Synergism | 2 | 2013 | 1792 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 139 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 1152 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2020 | 380 | 0.040 |
Why?
|
| Vaccines, Synthetic | 2 | 2014 | 634 | 0.040 |
Why?
|
| Schistosoma mansoni | 1 | 1999 | 149 | 0.040 |
Why?
|
| Cockroaches | 1 | 2019 | 96 | 0.040 |
Why?
|
| Edema | 1 | 2023 | 789 | 0.040 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 290 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2020 | 3701 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 873 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 7 | 1993 | 821 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2016 | 3386 | 0.040 |
Why?
|
| Cell Aggregation | 2 | 1996 | 244 | 0.040 |
Why?
|
| Citrobacter rodentium | 1 | 2018 | 66 | 0.040 |
Why?
|
| Binding Sites, Antibody | 1 | 1998 | 349 | 0.040 |
Why?
|
| Retina | 1 | 2009 | 2616 | 0.040 |
Why?
|
| Hormones | 1 | 2022 | 889 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 1999 | 247 | 0.040 |
Why?
|
| Single-Chain Antibodies | 1 | 2018 | 108 | 0.040 |
Why?
|
| Mucins | 1 | 2001 | 564 | 0.040 |
Why?
|
| Interleukin-5 | 2 | 2015 | 273 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 1999 | 1827 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2003 | 852 | 0.040 |
Why?
|
| Receptors, IgG | 2 | 2017 | 582 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 2019 | 245 | 0.040 |
Why?
|
| Preleukemia | 1 | 1997 | 35 | 0.040 |
Why?
|
| Acetylation | 1 | 2020 | 1085 | 0.040 |
Why?
|
| Species Specificity | 2 | 2020 | 2478 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 478 | 0.040 |
Why?
|
| Melanocytes | 1 | 2021 | 515 | 0.040 |
Why?
|
| Administration, Intravesical | 1 | 2017 | 91 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1999 | 473 | 0.040 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2017 | 90 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 449 | 0.040 |
Why?
|
| Intestines | 3 | 2013 | 1924 | 0.040 |
Why?
|
| Lipopolysaccharides | 3 | 2012 | 2216 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2013 | 363 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2022 | 1133 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2017 | 1730 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2018 | 2948 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39050 | 0.040 |
Why?
|
| Pregnancy | 1 | 2018 | 29144 | 0.040 |
Why?
|
| Crystallization | 2 | 2008 | 524 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2017 | 214 | 0.040 |
Why?
|
| Palatine Tonsil | 3 | 1999 | 193 | 0.040 |
Why?
|
| Serpins | 1 | 2018 | 247 | 0.040 |
Why?
|
| Skin Transplantation | 2 | 2013 | 1074 | 0.040 |
Why?
|
| Amino Acid Motifs | 2 | 2013 | 936 | 0.040 |
Why?
|
| Bone Marrow | 4 | 2009 | 2948 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2021 | 913 | 0.040 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 195 | 0.040 |
Why?
|
| Epidermal Growth Factor | 2 | 2015 | 708 | 0.040 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2019 | 629 | 0.040 |
Why?
|
| Chromatography, Gel | 1 | 2017 | 668 | 0.040 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 187 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 634 | 0.040 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2017 | 172 | 0.040 |
Why?
|
| Time Factors | 9 | 2015 | 40075 | 0.040 |
Why?
|
| Angiomyolipoma | 1 | 2018 | 190 | 0.040 |
Why?
|
| Thiophenes | 1 | 2021 | 588 | 0.040 |
Why?
|
| Mechlorethamine | 1 | 2016 | 136 | 0.030 |
Why?
|
| Antibodies, Viral | 3 | 2015 | 3176 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1970 | 0.030 |
Why?
|
| Micelles | 1 | 2017 | 203 | 0.030 |
Why?
|
| Anilides | 1 | 2019 | 408 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1998 | 1095 | 0.030 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 1996 | 139 | 0.030 |
Why?
|
| Phthalazines | 1 | 2018 | 363 | 0.030 |
Why?
|
| Cell Line, Transformed | 4 | 2000 | 898 | 0.030 |
Why?
|
| Biopsy | 2 | 2019 | 6756 | 0.030 |
Why?
|
| Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2020 | 1460 | 0.030 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 210 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 670 | 0.030 |
Why?
|
| Antigens, Ly | 2 | 2014 | 291 | 0.030 |
Why?
|
| Protein Transport | 2 | 2015 | 1988 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 557 | 0.030 |
Why?
|
| Data Mining | 1 | 2021 | 537 | 0.030 |
Why?
|
| Genes, cdc | 1 | 2016 | 116 | 0.030 |
Why?
|
| Antigens, CD20 | 2 | 2014 | 199 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 351 | 0.030 |
Why?
|
| Leukemia, Experimental | 1 | 1996 | 246 | 0.030 |
Why?
|
| Amines | 1 | 2017 | 276 | 0.030 |
Why?
|
| Allergens | 2 | 2019 | 1320 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2005 | 1434 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2020 | 1401 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 168 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2019 | 841 | 0.030 |
Why?
|
| Haptens | 3 | 2001 | 166 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2020 | 871 | 0.030 |
Why?
|
| Peyer's Patches | 1 | 2015 | 121 | 0.030 |
Why?
|
| Oxygen | 2 | 2017 | 4189 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1997 | 327 | 0.030 |
Why?
|
| Leukemia, Plasma Cell | 1 | 1995 | 48 | 0.030 |
Why?
|
| Bleomycin | 1 | 2016 | 512 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2015 | 86 | 0.030 |
Why?
|
| Restriction Mapping | 5 | 1996 | 878 | 0.030 |
Why?
|
| Receptors, IgE | 1 | 1996 | 389 | 0.030 |
Why?
|
| Chimera | 1 | 2016 | 485 | 0.030 |
Why?
|
| Gene Library | 4 | 2001 | 1074 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3479 | 0.030 |
Why?
|
| Glucose | 2 | 2017 | 4397 | 0.030 |
Why?
|
| Receptors, Interleukin-21 | 1 | 2014 | 33 | 0.030 |
Why?
|
| Mycosis Fungoides | 1 | 2016 | 163 | 0.030 |
Why?
|
| Oncolytic Viruses | 1 | 2018 | 327 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 1086 | 0.030 |
Why?
|
| Keratin-15 | 1 | 2014 | 22 | 0.030 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2014 | 48 | 0.030 |
Why?
|
| Etoposide | 1 | 2016 | 641 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2019 | 9849 | 0.030 |
Why?
|
| Keratin-5 | 1 | 2014 | 46 | 0.030 |
Why?
|
| Vinblastine | 1 | 2016 | 502 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2886 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 610 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2015 | 259 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2010 | 6544 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2016 | 408 | 0.030 |
Why?
|
| BCG Vaccine | 1 | 2017 | 369 | 0.030 |
Why?
|
| Cell Culture Techniques | 2 | 2017 | 1678 | 0.030 |
Why?
|
| Keratinocytes | 1 | 1998 | 798 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 1677 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 2016 | 252 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 1213 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2022 | 8301 | 0.030 |
Why?
|
| HLA-B7 Antigen | 1 | 1993 | 48 | 0.030 |
Why?
|
| Receptors, CXCR5 | 1 | 2014 | 92 | 0.030 |
Why?
|
| Kinetics | 3 | 2012 | 6473 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 27 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1994 | 1375 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 2017 | 11124 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
| Thymus Gland | 3 | 2005 | 1267 | 0.030 |
Why?
|
| Interleukin-6 | 3 | 1995 | 3200 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2013 | 55 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 627 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 809 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2006 | 370 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2019 | 1050 | 0.030 |
Why?
|
| Chemokine CCL4 | 1 | 2013 | 128 | 0.030 |
Why?
|
| ras Proteins | 2 | 2015 | 1060 | 0.030 |
Why?
|
| Pyrroles | 1 | 2019 | 1146 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2012 | 8 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2014 | 249 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 578 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 970 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 1866 | 0.030 |
Why?
|
| Young Adult | 5 | 2019 | 56430 | 0.030 |
Why?
|
| Oncolytic Virotherapy | 1 | 2018 | 498 | 0.030 |
Why?
|
| Pyrans | 1 | 1993 | 54 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2016 | 497 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 342 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 1312 | 0.030 |
Why?
|
| Leukemia, T-Cell | 1 | 1992 | 104 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1655 | 0.030 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2016 | 298 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2003 | 1861 | 0.030 |
Why?
|
| Campylobacter | 1 | 2012 | 59 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 284 | 0.030 |
Why?
|
| Intestine, Large | 1 | 2012 | 71 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2013 | 298 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 427 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 565 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 783 | 0.030 |
Why?
|
| Trichuris | 1 | 2012 | 32 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15540 | 0.030 |
Why?
|
| Case-Control Studies | 4 | 2013 | 21746 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2749 | 0.030 |
Why?
|
| Consensus Sequence | 3 | 1999 | 377 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1990 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2012 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2012 | 91 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1992 | 441 | 0.030 |
Why?
|
| Cystectomy | 1 | 2017 | 686 | 0.030 |
Why?
|
| Sialyltransferases | 1 | 1992 | 75 | 0.030 |
Why?
|
| Salmonella | 1 | 2012 | 129 | 0.030 |
Why?
|
| Ascitic Fluid | 2 | 2006 | 192 | 0.030 |
Why?
|
| Shigella | 1 | 2012 | 74 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12354 | 0.030 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2011 | 29 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 1085 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 940 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2011 | 17446 | 0.020 |
Why?
|
| Imidazoles | 1 | 2017 | 1206 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12245 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 481 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3920 | 0.020 |
Why?
|
| Herpesvirus 8, Human | 1 | 2013 | 258 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1991 | 245 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1991 | 299 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3297 | 0.020 |
Why?
|
| Fertility | 1 | 2016 | 781 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 598 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 828 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2015 | 981 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3479 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2017 | 1172 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 1993 | 548 | 0.020 |
Why?
|
| Capsid | 1 | 2013 | 436 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
| Argentina | 1 | 2011 | 232 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2016 | 1159 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1998 | 2263 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 1997 | 1263 | 0.020 |
Why?
|
| Fluorophotometry | 1 | 2009 | 40 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2010 | 99 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2021 | 2616 | 0.020 |
Why?
|
| Endosomes | 1 | 2013 | 520 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1993 | 786 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 1832 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2011 | 277 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2018 | 40561 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1403 | 0.020 |
Why?
|
| Ozone | 1 | 2013 | 469 | 0.020 |
Why?
|
| DNA Damage | 1 | 2019 | 2432 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2899 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2020 | 77449 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2015 | 1119 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2019 | 1972 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1996 | 1341 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 1917 | 0.020 |
Why?
|
| Pancreas | 2 | 2007 | 1686 | 0.020 |
Why?
|
| Antigens, T-Independent | 2 | 1999 | 21 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 1 | 2009 | 65 | 0.020 |
Why?
|
| Tacrolimus | 1 | 1993 | 743 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 389 | 0.020 |
Why?
|
| Infectious Mononucleosis | 1 | 2009 | 131 | 0.020 |
Why?
|
| Bacteriophage phi X 174 | 1 | 2008 | 20 | 0.020 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2013 | 329 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2013 | 721 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 428 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 1989 | 291 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18370 | 0.020 |
Why?
|
| G1 Phase | 2 | 2000 | 415 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 3462 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 572 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2008 | 188 | 0.020 |
Why?
|
| Endocytosis | 1 | 2013 | 985 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1996 | 708 | 0.020 |
Why?
|
| Piperazines | 1 | 2018 | 2488 | 0.020 |
Why?
|
| Antibodies, Heterophile | 1 | 2008 | 126 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2008 | 337 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 644 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1997 | 1519 | 0.020 |
Why?
|
| Dogs | 1 | 2013 | 3912 | 0.020 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2007 | 59 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1375 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2010 | 612 | 0.020 |
Why?
|
| Syndrome | 1 | 2014 | 3251 | 0.020 |
Why?
|
| Lysosomes | 1 | 2013 | 893 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 1989 | 376 | 0.020 |
Why?
|
| Mice, Inbred DBA | 2 | 2001 | 642 | 0.020 |
Why?
|
| Hepatitis B Antigens | 1 | 2007 | 40 | 0.020 |
Why?
|
| Oncogenes | 1 | 2013 | 1265 | 0.020 |
Why?
|
| Pyridines | 1 | 2019 | 2825 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1941 | 0.020 |
Why?
|
| Cross-Priming | 1 | 2007 | 82 | 0.020 |
Why?
|
| Metabolome | 1 | 2014 | 895 | 0.020 |
Why?
|
| Rabbits | 1 | 2014 | 4894 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 437 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2017 | 2416 | 0.020 |
Why?
|
| DNA Fragmentation | 2 | 1997 | 242 | 0.020 |
Why?
|
| Epithelium, Corneal | 1 | 2009 | 247 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2282 | 0.020 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2006 | 20 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2008 | 613 | 0.020 |
Why?
|
| Receptors, Complement | 2 | 2001 | 264 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2007 | 421 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 1991 | 2124 | 0.020 |
Why?
|
| TYK2 Kinase | 1 | 2006 | 38 | 0.020 |
Why?
|
| Blood | 1 | 2009 | 598 | 0.020 |
Why?
|
| Chromatin | 1 | 2018 | 2934 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1889 | 0.020 |
Why?
|
| Glycosylation | 2 | 2001 | 1126 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 1991 | 1179 | 0.020 |
Why?
|
| Leishmania mexicana | 1 | 2006 | 31 | 0.020 |
Why?
|
| Phytohemagglutinins | 2 | 1996 | 170 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2219 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 1905 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 1401 | 0.020 |
Why?
|
| Toxoplasmosis | 1 | 2006 | 91 | 0.020 |
Why?
|
| Clonal Deletion | 1 | 2005 | 79 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3647 | 0.020 |
Why?
|
| United States | 3 | 2021 | 69872 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1620 | 0.020 |
Why?
|
| Janus Kinase 3 | 2 | 1996 | 78 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 300 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 712 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1989 | 822 | 0.020 |
Why?
|
| Chemokines | 1 | 2009 | 970 | 0.020 |
Why?
|
| Toxoplasma | 1 | 2006 | 150 | 0.020 |
Why?
|
| Bacteremia | 1 | 2012 | 962 | 0.020 |
Why?
|
| STAT4 Transcription Factor | 1 | 2004 | 96 | 0.020 |
Why?
|
| Solubility | 2 | 1999 | 1085 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2009 | 646 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1856 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2007 | 442 | 0.020 |
Why?
|
| Profilins | 1 | 2004 | 66 | 0.020 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2004 | 42 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 4 | 2001 | 5867 | 0.020 |
Why?
|
| Pneumonia | 1 | 2016 | 2133 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 3521 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 1996 | 964 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2009 | 1355 | 0.010 |
Why?
|
| Genomics | 1 | 2020 | 5720 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 1519 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2005 | 378 | 0.010 |
Why?
|
| Pseudopodia | 1 | 2004 | 172 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2011 | 1151 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 480 | 0.010 |
Why?
|
| Immunogenetics | 1 | 2003 | 67 | 0.010 |
Why?
|
| Homeostasis | 1 | 2015 | 3340 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9313 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 3617 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 489 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1989 | 1354 | 0.010 |
Why?
|
| Kidney | 1 | 2019 | 7186 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7913 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3597 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2009 | 2726 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2011 | 2740 | 0.010 |
Why?
|
| Hepatitis B virus | 1 | 2007 | 513 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2002 | 29 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2004 | 200 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2002 | 32 | 0.010 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2002 | 57 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1998 | 3079 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 625 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 1224 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8340 | 0.010 |
Why?
|
| Proline | 1 | 2004 | 458 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2006 | 959 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2006 | 1682 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 9959 | 0.010 |
Why?
|
| Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2006 | 1588 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 733 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3508 | 0.010 |
Why?
|
| Telomere | 1 | 2008 | 910 | 0.010 |
Why?
|
| Child | 3 | 2017 | 77709 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 25043 | 0.010 |
Why?
|
| Leukopoiesis | 1 | 2002 | 56 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2009 | 1322 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2009 | 1211 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 464 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2001 | 90 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1801 | 0.010 |
Why?
|
| GATA3 Transcription Factor | 1 | 2002 | 157 | 0.010 |
Why?
|
| Receptors, Complement 3b | 1 | 2001 | 145 | 0.010 |
Why?
|
| Smad2 Protein | 1 | 2001 | 156 | 0.010 |
Why?
|
| Neoplasm Transplantation | 2 | 1996 | 2085 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2015 | 4286 | 0.010 |
Why?
|
| Smad4 Protein | 1 | 2001 | 163 | 0.010 |
Why?
|
| Gene Products, tax | 1 | 2000 | 51 | 0.010 |
Why?
|
| Adolescent | 3 | 2016 | 85781 | 0.010 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2000 | 71 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 1537 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 293 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1989 | 1401 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2001 | 158 | 0.010 |
Why?
|
| Immune Sera | 1 | 2000 | 641 | 0.010 |
Why?
|
| Submitochondrial Particles | 1 | 1999 | 5 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13408 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 424 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 403 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 7729 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2001 | 417 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 2000 | 101 | 0.010 |
Why?
|
| Caenorhabditis elegans | 2 | 1999 | 1419 | 0.010 |
Why?
|
| Sirolimus | 1 | 2007 | 1564 | 0.010 |
Why?
|
| Integrins | 1 | 2004 | 846 | 0.010 |
Why?
|
| Bees | 1 | 1999 | 43 | 0.010 |
Why?
|
| Nocodazole | 1 | 1999 | 97 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2008 | 2902 | 0.010 |
Why?
|
| Immunization | 1 | 2004 | 1256 | 0.010 |
Why?
|
| Research Design | 1 | 2015 | 5987 | 0.010 |
Why?
|
| Dermatitis, Contact | 1 | 1999 | 129 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 433 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12959 | 0.010 |
Why?
|
| Microspheres | 1 | 2002 | 777 | 0.010 |
Why?
|
| Interphase | 1 | 1999 | 226 | 0.010 |
Why?
|
| Cornea | 1 | 2007 | 1524 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2000 | 323 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2001 | 2255 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1999 | 484 | 0.010 |
Why?
|
| Electron Transport Complex I | 1 | 1999 | 140 | 0.010 |
Why?
|
| Smoking | 1 | 2015 | 8987 | 0.010 |
Why?
|
| Risk Factors | 2 | 2016 | 72290 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 319 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9687 | 0.010 |
Why?
|
| Quality of Life | 1 | 2019 | 12804 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1999 | 349 | 0.010 |
Why?
|
| rap GTP-Binding Proteins | 1 | 1997 | 28 | 0.010 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 1997 | 34 | 0.010 |
Why?
|
| Thymidine | 1 | 1998 | 310 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2307 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 1998 | 171 | 0.010 |
Why?
|
| Cyclins | 1 | 2000 | 603 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 1997 | 107 | 0.010 |
Why?
|
| Microcirculation | 1 | 2002 | 1286 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 1997 | 119 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2001 | 880 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1997 | 139 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1997 | 216 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 321 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 2121 | 0.010 |
Why?
|
| Caspase 1 | 1 | 1997 | 224 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2008 | 2119 | 0.010 |
Why?
|
| Introns | 1 | 1999 | 991 | 0.010 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1996 | 91 | 0.010 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 1996 | 67 | 0.010 |
Why?
|
| Mitogens | 1 | 1996 | 232 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1997 | 295 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 12951 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1999 | 1202 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1997 | 411 | 0.010 |
Why?
|
| Interleukin-7 | 1 | 1996 | 142 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1995 | 82 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1996 | 457 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 1994 | 107 | 0.010 |
Why?
|
| Leukotriene A4 | 1 | 1994 | 26 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1526 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 563 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 1 | 1994 | 112 | 0.010 |
Why?
|
| Genomic Library | 1 | 1994 | 193 | 0.010 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 1 | 1994 | 32 | 0.010 |
Why?
|
| Cricetulus | 1 | 1996 | 816 | 0.010 |
Why?
|
| Microsomes | 1 | 1994 | 257 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 1993 | 80 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1995 | 261 | 0.010 |
Why?
|
| Homozygote | 1 | 1999 | 1785 | 0.010 |
Why?
|
| Leukotriene C4 | 1 | 1994 | 97 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 1995 | 311 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 1708 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 3922 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1994 | 256 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 1999 | 1058 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1999 | 1869 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1992 | 191 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1998 | 1072 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1995 | 841 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1995 | 434 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1995 | 436 | 0.010 |
Why?
|
| Electroporation | 1 | 1993 | 251 | 0.010 |
Why?
|
| Calcimycin | 1 | 1992 | 222 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1992 | 148 | 0.010 |
Why?
|
| Glutathione | 1 | 1994 | 589 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15076 | 0.010 |
Why?
|
| Neuraminidase | 1 | 1992 | 210 | 0.010 |
Why?
|
| Glycolipids | 1 | 1992 | 204 | 0.010 |
Why?
|
| Receptors, Complement 3d | 1 | 1991 | 118 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1992 | 291 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1994 | 1950 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1993 | 936 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1992 | 410 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4982 | 0.010 |
Why?
|
| Testosterone | 1 | 1999 | 2420 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 35136 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 41006 | 0.000 |
Why?
|
| DNA Probes | 1 | 1989 | 560 | 0.000 |
Why?
|
| Tissue and Organ Procurement | 1 | 1996 | 896 | 0.000 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1988 | 349 | 0.000 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1996 | 1270 | 0.000 |
Why?
|
| Genes, Viral | 1 | 1988 | 718 | 0.000 |
Why?
|
| Cross-Linking Reagents | 1 | 1989 | 694 | 0.000 |
Why?
|
| Remission Induction | 1 | 1991 | 2386 | 0.000 |
Why?
|
| Stem Cells | 1 | 1999 | 3567 | 0.000 |
Why?
|
| Salvage Therapy | 1 | 1991 | 1275 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1995 | 2942 | 0.000 |
Why?
|
| Brain | 1 | 2009 | 26385 | 0.000 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1988 | 2232 | 0.000 |
Why?
|
| Calcium | 1 | 1992 | 5756 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1989 | 2752 | 0.000 |
Why?
|